SG11201805170XA - Cellular glycosaminoglycan compositions and methods of making and using - Google Patents
Cellular glycosaminoglycan compositions and methods of making and usingInfo
- Publication number
- SG11201805170XA SG11201805170XA SG11201805170XA SG11201805170XA SG11201805170XA SG 11201805170X A SG11201805170X A SG 11201805170XA SG 11201805170X A SG11201805170X A SG 11201805170XA SG 11201805170X A SG11201805170X A SG 11201805170XA SG 11201805170X A SG11201805170X A SG 11201805170XA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- california
- san diego
- pct
- applicant
- Prior art date
Links
- 229920002683 Glycosaminoglycan Polymers 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- 230000001413 cellular effect Effects 0.000 title abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 239000013256 coordination polymer Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000011521 glass Substances 0.000 abstract 1
- 230000008520 organization Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Materials Engineering (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562269879P | 2015-12-18 | 2015-12-18 | |
| PCT/US2016/067373 WO2017106782A1 (fr) | 2015-12-18 | 2016-12-16 | Compositions de glycosaminoglycane cellulaire et leurs procédés de préparation et d'utilisation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201805170XA true SG11201805170XA (en) | 2018-07-30 |
Family
ID=59057730
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201805170XA SG11201805170XA (en) | 2015-12-18 | 2016-12-16 | Cellular glycosaminoglycan compositions and methods of making and using |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US11549000B2 (fr) |
| EP (1) | EP3389674A4 (fr) |
| CN (1) | CN108697730A (fr) |
| AU (1) | AU2016369595B2 (fr) |
| CA (1) | CA3008848A1 (fr) |
| SG (1) | SG11201805170XA (fr) |
| WO (1) | WO2017106782A1 (fr) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3008848A1 (fr) | 2015-12-18 | 2017-06-22 | Tega Therapeutics, Inc. | Compositions de glycosaminoglycane cellulaire et leurs procedes de preparation et d'utilisation |
| WO2018180005A1 (fr) * | 2017-03-31 | 2018-10-04 | 国立研究開発法人日本医療研究開発機構 | Acide nucléique antisens pour l'inhibition de la biosynthèse de sulfate de chondroïtine |
| CN109825579B (zh) * | 2019-01-23 | 2020-01-14 | 山东大学齐鲁医院 | Galnt2作为生物标志物在胶质瘤诊断和/或治疗中的应用 |
| WO2020225871A1 (fr) * | 2019-05-08 | 2020-11-12 | 株式会社Ｔмｅセラピューティックス | Médicament pour atténuer un rétrécissement de l'œsophage |
| US20220333144A1 (en) * | 2019-09-10 | 2022-10-20 | Rensselaer Polytechnic Institute | Recombinant microorganisms for in vivo production of sulfated glycosaminoglycans |
| WO2021188882A1 (fr) * | 2020-03-19 | 2021-09-23 | Glycologix, Llc | Biomatériaux à base de glycosaminoglycanes sulfatés utilisés en tant que mimétiques de protéoglycanes |
| DE102020007691A1 (de) | 2020-12-16 | 2022-06-23 | Forschungszentrum Jülich GmbH | Verfahren zur Identifizierung und/oder zum Erhalten eines Wirkstoffs zur Behandlung und Therapie der familiären amyotrophen Lateralsklerose sowie Verwendung eines Wirkstoffs zur Behandlung dieser Erkrankung |
| WO2023118313A1 (fr) | 2021-12-21 | 2023-06-29 | University Of Copenhagen | Héparane sulfate amélioré et ses procédés de fabrication |
| CN115094090B (zh) * | 2022-05-30 | 2024-01-19 | 北京清华长庚医院 | 特定硫酸肝素修饰酶基因修饰的细胞及其构建方法和应用 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5740503A (en) | 1980-08-22 | 1982-03-06 | Seikagaku Kogyo Co Ltd | Separation of saccharides |
| NO161573C (no) | 1983-11-25 | 1989-08-30 | Miles Inc | Fremgangsmaate til fremstilling av hyaluronsyre. |
| US5023175A (en) | 1986-05-01 | 1991-06-11 | Kabushiki Kaisha Yakult Honsha | Novel production process of hyaluronic acid and bacterium strain therefor |
| AU5810690A (en) | 1989-05-19 | 1990-12-18 | University Of Alabama, The | Heparin-producing murine mastocytoma cell lines |
| AU6872691A (en) | 1989-10-27 | 1991-05-31 | Case Western Reserve University | Inhibition of cell growth by keratan sulfate, chondroitin sulfate, dermatan sulfate and other glycans |
| US5104856A (en) | 1990-11-09 | 1992-04-14 | Uab Research Foundation | Heparan sulfate biosynthesis primers |
| IL144446A0 (en) | 2001-07-19 | 2002-05-23 | Prochon Biotech Ltd | Plasma protein matrices and methods for their preparation |
| US20030139333A1 (en) | 2002-01-18 | 2003-07-24 | Genetix Pharmaceuticals, Inc. | Methods and compositions for promoting angiogenesis |
| WO2004050673A2 (fr) * | 2002-11-27 | 2004-06-17 | Massachusetts Institute Of Technology | Methodes pour synthetiser des polysaccharides |
| WO2005100374A1 (fr) | 2004-04-19 | 2005-10-27 | Curtin University Of Technology | Heparines therapeutiques et leur liaison aux interleukines 4 et 5, et pecam-1 |
| FI20065035A (fi) | 2006-01-19 | 2007-07-20 | Polysackaridforskning I Uppsal | Olennaisesti puhdas entsyymi |
| WO2008036741A2 (fr) | 2006-09-19 | 2008-03-27 | Asuragen, Inc. | Gènes et voies régulés par mir-200 servant de cibles dans le cadre d'une intervention thérapeutique |
| WO2008116889A1 (fr) | 2007-03-26 | 2008-10-02 | Institut Pasteur | Nouveau modèle in vitro de mastocytes de type séreux matures servant à l'analyse de maladies autoimmunes et d'inflammations allergiques |
| GB0818255D0 (en) | 2008-10-06 | 2008-11-12 | Agency Science Tech & Res | Isolation and identification of glycosaminoglycans |
| US9359452B2 (en) | 2009-11-20 | 2016-06-07 | Agency For Science, Technology And Research | Isolation and characterisation of heparan sulphates and their use in pharmaceutical compositions, methods of treatment and stem cell culture media suitable for conditions associated with bone repair |
| US20120295890A1 (en) | 2009-12-31 | 2012-11-22 | Zacharon Pharmaceutical, Inc. | Glycosaminoglycan inhibitors |
| US20130189275A1 (en) * | 2010-06-03 | 2013-07-25 | University Of Rochester | Compositions and methods for inhibition of or treatment of dengue virus infection |
| JP5576729B2 (ja) * | 2010-07-05 | 2014-08-20 | オリンパス株式会社 | 光調節装置 |
| FR2981945B1 (fr) | 2011-11-02 | 2016-09-23 | Centre Nat Rech Scient | Lignees de mastocytes humains, preparation et utilisations |
| WO2014185858A1 (fr) * | 2013-05-16 | 2014-11-20 | Agency For Science, Technology And Research | Sulfates d'héparane |
| CN106715707A (zh) | 2014-06-18 | 2017-05-24 | 免疫医疗公司 | 包含n‑乙酰半胱氨酸的细胞培养方法和培养基 |
| US10858671B2 (en) | 2014-12-12 | 2020-12-08 | University Of Copenhagen | N-glycosylation |
| EP3289086A4 (fr) | 2015-04-30 | 2018-11-07 | NewSouth Innovations Pty Limited | Procédé de production d'héparine et d'héparane sulfate |
| CA3008848A1 (fr) | 2015-12-18 | 2017-06-22 | Tega Therapeutics, Inc. | Compositions de glycosaminoglycane cellulaire et leurs procedes de preparation et d'utilisation |
| US20200038430A1 (en) | 2016-12-16 | 2020-02-06 | Tega Therapeutics, Inc. | In vitro heparin and heparan sulfate compositions and methods of making and using |
| CA3152781A1 (fr) | 2019-08-27 | 2021-03-04 | Tega Therapeutics, Inc. | Heparine et sulfate d'heparane issus de cellules mst modifiees et procedes de fabrication et d'utilisation |
-
2016
- 2016-12-16 CA CA3008848A patent/CA3008848A1/fr active Pending
- 2016-12-16 US US16/063,670 patent/US11549000B2/en active Active
- 2016-12-16 EP EP16876865.3A patent/EP3389674A4/fr active Pending
- 2016-12-16 CN CN201680082199.4A patent/CN108697730A/zh active Pending
- 2016-12-16 WO PCT/US2016/067373 patent/WO2017106782A1/fr active Application Filing
- 2016-12-16 AU AU2016369595A patent/AU2016369595B2/en active Active
- 2016-12-16 SG SG11201805170XA patent/SG11201805170XA/en unknown
-
2022
- 2022-12-09 US US18/064,181 patent/US20240026404A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3389674A1 (fr) | 2018-10-24 |
| WO2017106782A1 (fr) | 2017-06-22 |
| CN108697730A (zh) | 2018-10-23 |
| CA3008848A1 (fr) | 2017-06-22 |
| US20240026404A1 (en) | 2024-01-25 |
| US11549000B2 (en) | 2023-01-10 |
| AU2016369595B2 (en) | 2022-11-24 |
| EP3389674A4 (fr) | 2019-09-11 |
| AU2016369595A1 (en) | 2018-08-02 |
| US20200332088A1 (en) | 2020-10-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201805170XA (en) | Cellular glycosaminoglycan compositions and methods of making and using | |
| SG11201908330PA (en) | Farnesoid x receptor agonists and uses thereof | |
| SG11201903882VA (en) | Il-2 variants for the treatment of autoimmune diseases | |
| SG11201806322QA (en) | Maytansinoid derivatives, conjugates thereof, and methods of use | |
| SG11201809751XA (en) | Egfr inhibitor compounds | |
| SG11201808196UA (en) | Neoantigens and methods of their use | |
| SG11201809344QA (en) | Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehyde | |
| SG11201804375WA (en) | Compositions and methods for internalizing enzymes | |
| SG11201903697WA (en) | Liver organoid compositions and methods of making and using same | |
| SG11201906301UA (en) | Methods of manufacture of nut flours and formulations for oral immunotherapy | |
| SG11201807784SA (en) | 3-desoxy derivative and pharmaceutical compositions thereof | |
| SG11201407579QA (en) | Interleukin-2 fusion proteins and uses thereof | |
| SG11201810525XA (en) | Anti-gitr antibodies and uses thereof | |
| SG11201806758VA (en) | Vcn enhancer compositions and methods of using the same | |
| SG11201907023UA (en) | Method of reducing neutropenia | |
| SG11201408787PA (en) | Enhancing activity of car t cells by co-introducing a bispecific antibody | |
| SG11201900554YA (en) | Spiro-lactam nmda modulators and methods of using same | |
| SG11201904535VA (en) | Prevention and treatment of bone and cartilage damage or disease | |
| SG11201908512YA (en) | Somatostatin modulators and uses thereof | |
| SG11201811230RA (en) | Compositions and methods for reducing ocular neovascularization | |
| SG11201808713YA (en) | Ophthalmic compositions comprising levodopa, an antioxidant and an aqueous carrier | |
| SG11201810872UA (en) | Composition and method for reducing neutropenia | |
| SG11201809374VA (en) | Cd40l-fc fusion polypeptides and methods of use thereof | |
| SG11201900551WA (en) | Spiro-lactam nmda receptor modulators and uses thereof | |
| SG11201900546UA (en) | Spiro-lactam and bis-spiro-lactam nmda receptor modulators and uses thereof |